CAT
Caterpillar Inc.
CAT has the edge over TRI overall, supported by stronger modeled upside and stronger fundamentals.
TRI
Thomson Reuters Corporation
TRI offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
TRI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Healthy |
TRI's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over TRI in the historical PE scenario, which offers more potential upside but is not a forecast.
TRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $44.01 | -60% |
| Forward | 25x | $109 | — |
| Current | 29x | $109 | — |
| Fair | 30x | $111 | +1.2% |
| Expensive | 44x | $163 | +49% |
Historical ranges are pointers, not guarantees.
TRI's PE is in its fair range at 29x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its cheap range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
TRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TRI, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over TRI on earnings, with more consistent year-over-year improvement.
TRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.45 | +19% |
| Q2 2026 | $3.74 | +4.5% |
| Q1 2026 | $3.42 | -28% |
| Q4 2025 | $3.35 | -31% |
| Q3 2025 | $3.85 | -25% |
| Q2 2025 | $3.58 | -32% |
| Q1 2025 | $4.75 | -10% |
| Q4 2024 | $4.85 | -16% |
| Q3 2024 | $5.12 | +6% |
TRI's earnings per share have fallen from their peak: $3.74 over the past year, against $13.97 in mid-2021.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
TRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2B | +9.5% |
| Q1 2026 | $2.1B | +9.8% |
| Q4 2025 | $2B | +5.2% |
| Q3 2025 | $1.8B | +3.4% |
| Q2 2025 | $1.8B | +2.6% |
| Q1 2025 | $1.9B | +0.8% |
| Q4 2024 | $1.9B | +5.2% |
| Q3 2024 | $1.7B | +8.2% |
TRI's revenue has grown year over year every quarter since late 2020: $2B last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | +4.1 points |
| Q1 2026 | 30% | +0.8 points |
| Q4 2025 | 19% | -19 points |
| Q3 2025 | 33% | +9.2 points |
| Q2 2025 | 24% | +0.6 points |
| Q1 2025 | 30% | +0.1 points |
| Q4 2024 | 38% | +7.1 points |
| Q3 2024 | 24% | -3.6 points |
TRI has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
TRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $722.3M | +21% |
| Q1 2026 | $349M | +19% |
| Q4 2025 | $607.4M | +54% |
| Q3 2025 | $537.3M | -12% |
| Q2 2025 | $597.9M | +8.5% |
| Q1 2025 | $293.1M | +2.6% |
| Q4 2024 | $395M | -33% |
| Q3 2024 | $609.5M | +16% |
TRI has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
TRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +820K shares |
| 1 year | -2.8% | -12.6M shares |
| 3 years | -6.8% | -31.8M shares |
| 5 years | -8.5% | -40.7M shares |
| Available history | -9.2% | -44.6M shares |
TRI has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $685.1M |
| Q1 2026 | $262M |
| Q4 2025 | $335.3M |
| Q3 2025 | $672.7M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $34,300 |
TRI spent $2B buying back its own shares over the past year, more than ten times what it spent the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over TRI on leverage, with a lower net debt burden relative to earnings.
TRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
| Q3 2024 | 0.6x | Very low |
TRI's net debt is less than a year of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 65.0 | Neutral |
TRI's weekly RSI is 54 (neutral) and its Stochastic is 65 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over TRI on valuation relative to its sector.
TRI PE vs Industrials Sector
| Metric | TRI | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 24x | 22% above |
| PE % | 48 | 58 | 10 pts below |
TRI is trading at 29x earnings, a 22% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
TRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.0 | 0.2% above |
| 20 week MA | $102.5 | 6.6% above |
| 50 week MA | $101.7 | 7.4% above |
| 100 week MA | $139.1 | 21% below |
| 200 week MA | $144.0 | 24% below |
TRI has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over TRI on returns for 2026, with the stronger performance.
TRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $75.8 | $85.0 | +12% |
| 2021 | $85.0 | $123.2 | +45% |
| 2022 | $123.2 | $119.5 | -3% |
| 2023 | $119.5 | $148.6 | +24% |
| 2024 | $148.6 | $164.6 | +11% |
| 2025 | $164.6 | $135.4 | -18% |
| 2026 YTD | $135.4 | $109.3 | -19% |
TRI has finished higher in four of the last six years. It's down 19% so far in 2026.